Publication | Open Access
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia
159
Citations
33
References
2015
Year
Hematological MalignancyTumor BiologyLeukemic CellsMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaReceptor Tyrosine KinaseImmunologyFlt3-targeted TherapyMedicineCell BiologyCell SignalingCancer ResearchMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1